New PET scan could spot amyloid buildup more clearly
NCT ID NCT05235269
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tested a new imaging agent (124I AT-01) used with PET/CT scans to see how well it can measure amyloid deposits in organs like the heart, kidneys, liver, and spleen. 33 adults with systemic amyloidosis (AL or ATTR types) received the agent and were scanned twice to check if the results were consistent. The goal was to improve how doctors detect and track this rare disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northern California PET Imaging Center
Sacramento, California, 95816, United States
-
PET/CT Imaging of Berkeley
Berkeley, California, 94705, United States
-
PET/CT Imaging of San Jose
San Jose, California, 95128, United States
Conditions
Explore the condition pages connected to this study.